Lupin acquires five brands and associated trademark rights from Menarini
Indian pharmaceutical firm Lupin has entered into an agreement to acquire five brands along with associated trademark rights from the units of Menarini.
Stay updated with breaking news from Otilonium Bromide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indian pharmaceutical firm Lupin has entered into an agreement to acquire five brands along with associated trademark rights from the units of Menarini.
Drug firm Lupin on Friday said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. ‘The company has signed an agreement to acquire five legacy brands catering to gastroenterology, urology and anti-infective segments, the Mumbai-based company said in a
Lupin has been exclusively marketing these brands in the Indian market since July 2021 under a distribution and promotion agreement with A. Menarini India Private Limited.
The brands belong to strategic therapy areas of Gastroenterology, Anti-infectives and Urology, Lupin said in a filing to the stock exchanges.
Strengthens its Position and Key Therapy Portfolio in India Mumbai, September 22, 2023: Global pharma major Lupin Limited announced today that it has signed an...